There is no adult or performance-related FDA indication for any IGF-1 product
doi:10.3390/jcm10061202 [41] Berry-Kravis E, Booth G, Sanchez AC, Woodbury-Kolb J
Additionally, FDA regulations also prohibit reminder ads for drugs that have boxed warnings.[16] Since Ozempic, Mounjaro, Saxenda, and Wegovy have boxed warnings as a result of a risk of thyroid c-cell tumors, FDA regulations do not permit reminder advertisements for such drug products.[17] Third, the Advertisement does not comply with FDA guidance
Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury
Any suspected adverse reactions can be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Think thicker serums or HA combined with emollients